176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-3.47%
Both yoy net incomes decline, with TSM at -3.75%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
0.94%
Less D&A growth vs. TSM's 3.42%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-30.43%
Negative yoy deferred tax while TSM stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
1.82%
SBC growth while TSM is negative at -1.33%. John Neff would see competitor possibly controlling share issuance more tightly.
-316.27%
Both reduce yoy usage, with TSM at -600.50%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-23.27%
Both yoy AR lines negative, with TSM at -233.56%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-328.79%
Negative yoy inventory while TSM is 38.18%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-31.73%
Both negative yoy AP, with TSM at -3209.20%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-115.15%
Both reduce yoy usage, with TSM at -108.71%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-96.83%
Both negative yoy, with TSM at -94.41%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-37.95%
Both yoy CFO lines are negative, with TSM at -12.08%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-7.64%
Both yoy lines negative, with TSM at -179.08%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-750.00%
Both yoy lines negative, with TSM at -30.72%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-9533.33%
Both yoy lines negative, with TSM at -0.86%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-50.00%
We reduce yoy sales while TSM is 7.76%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-43200.00%
We reduce yoy other investing while TSM is 267.75%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-598.68%
Both yoy lines negative, with TSM at -168.53%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-152.27%
We cut yoy buybacks while TSM is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.